Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 01 Oct 2026 for Enliven Therapeutics, Inc., €535k. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
No signal scores available.
Jeffrey Garland: trading record in brief
Jeffrey Garland has a single filing on record, published on 1 October 2026: a transaction of €535k in Enliven Therapeutics, Inc. One trade is not enough to describe a pattern. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Jeffrey Garland
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
13,000 shares@ US$46.6707CommonSEC144:0001950047-26-009907
1 of 1 declaration
